Drugs / GrafixPL PRIME
last change Mar 2020 re-read 3 minutes ago

GrafixPL PRIME

Developed for
ulcer of lower limbs
Investigated by
Osiris Therapeutics · University of Texas Southwestern Medical Center

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03742440 Nov 2018 → Mar 2020 ulcer of lower limbs University of Texas Southwestern Medical Center Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GrafixPL PRIME ClinicalTrials.gov intervention name — accepted as the source's own label NCT03742440 ↗